Title of article :
Identification of Three Novel Mutations in the FANCA, FANCC, and ITGA2B Genes by Whole Exome Sequencing
Author/Authors :
Negahdari, Samira Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Zamani, Mina Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Seifi, Tahereh Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Sedighzadeh, Sahar Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Mazaheri, Neda Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Zeighami, Jawaher Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Sedaghat, Alireza Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Saberi, Alihossein Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Hamid, Mohammad Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , keikhaei, Bijan Health Research Institute - Research Centre of Thalassemia and Hemoglobinopathies - Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran , Radpour, Ramin Tumor Immunology - Department for BioMedical Research (DBMR) - University of Bern, Bern, Switzerland , Shariati, Gholamreza Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Galehdari, Hamid Health Research Institute - Research Centre of Thalassemia and Hemoglobinopathies - Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Pages :
7
From page :
1
To page :
7
Abstract :
Background: Various blood diseases are caused by mutations in the FANCA, FANCC, and ITGA2B genes. Exome sequencing is a suitable method for identifying single‑gene disease and genetic heterogeneity complaints. Methods: Among families who were referred to Narges Genetic and PND Laboratory in 2015‑2017, five families with a history of blood diseases were analyzed using the whole exome sequencing (WES) method. Results: We detected two novel mutations (c.190‑2A>G and c.2840C>G) in the FANCA gene, c. 1429dupA mutation in the FANCC gene, and c.1392A>G mutation in the ITGA2B gene. The prediction of variant pathogenicity has been done using bioinformatics tools such as Mutation taster PhD‑SNP and polyphen2 and were confirmed by Sanger sequencing. Conclusions: WES could be as a precise tool for identifying the pathologic variants in affected patient and heterozygous carriers among families. This highly successful technique will remain at the forefront of platelet and blood genomic research.
Keywords :
sequence analysis , Fanconi anemia , DNA , congenital abnormalities , Blood platelets
Journal title :
International Journal of Preventive Medicine (IJPM)
Serial Year :
2020
Record number :
2610460
Link To Document :
بازگشت